RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Turk J Gastroenterol. 2023 Mar;34(3):310. doi: 10.5152/tjg.2023.237002.
No abstract available

MeSH terms

  • Biological Therapy
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens*
  • Hepatitis B virus* / physiology
  • Humans
  • Immunoglobulin G


  • Hepatitis B Surface Antigens
  • Hepatitis B Antibodies
  • Immunoglobulin G